InvestorsHub Logo
Post# of 252412
Next 10
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

Re: None

Thursday, 06/18/2015 2:24:45 PM

Thursday, June 18, 2015 2:24:45 PM

Post# of 252412
Seres Therapeutics:

Watching a retail roadshow presentation of an interesting company with a different approach (then I am familiar with at least). Their lead program is for recurrent C Diff, SER-109. They have a breakthrough designation already for those who care about those things. The CEO sounds a bit overly confident (maybe that is good though). What makes them unusual (to me) is their approach From their website

Seres is developing Ecobiotic® therapeutics to treat diseases that have an underlying microbiome biology



Here is a link to their website
http://serestherapeutics.com/

Retail Roadshow link:
http://www.retailroadshow.com/sys/launch.asp?k=62437033451 if that doesn't work try the below or from the retailroadshow website.
http://t.co/QGFHLPDWJH

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.